Oculus Innovative Sciences to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

Show Health and Fitness Publications

Thu, February 19, 2009

[ Thu, Feb 19th 2009 ] - Market Wire

MiddleBrook Pharmaceuticals Schedules Conference .. 08 Fourth Quarter and Full-Year Financial Results

[ Thu, Feb 19th 2009 ] - Market Wire

Enzon Reports 2008 Results

[ Thu, Feb 19th 2009 ] - Market Wire

Invacare Corporation Announces Appointment of Dale C. LaPorte to Board of Directors

[ Thu, Feb 19th 2009 ] - Market Wire

Forensic DNA Shown to Lower Crime Rates and Decrease Property Loss

[ Thu, Feb 19th 2009 ] - Market Wire

Antigenics Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights

Wed, February 18, 2009

[ Wed, Feb 18th 2009 ] - Market Wire

Publicatie van landmarkstudie in The Lancet Oncol .. ziene algehele overleving met Vidaza® van Celgen

[ Wed, Feb 18th 2009 ] - Market Wire

Resumen: Estudio revelador publicado en The Lance .. � de Celgene demuestra supervivencia sin preceden

[ Wed, Feb 18th 2009 ] - Market Wire

Remedent, Inc.: Remedent Sets Third Fiscal Quarte .. ce Call for Tuesday, February 24 at 11:00 a.m. ET

[ Wed, Feb 18th 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma Receives Nasdaq Notice Related to Audit Committee Composition

[ Wed, Feb 18th 2009 ] - Market Wire

USANA Recognized as Newest Member of the Council for Responsible Nutrition

[ Wed, Feb 18th 2009 ] - Market Wire

Orthofix International to Participate in Canaccord Adams Musculoskeletal Conference

[ Wed, Feb 18th 2009 ] - Market Wire

DelSite, Inc: DelSite Announces Intention to Lice .. nufacturing Rights, Fields of Use and Territories

[ Wed, Feb 18th 2009 ] - Market Wire

FONAR Corporation: FONAR Reports Profit and 2nd Quarter Fiscal 2009 Financial Results

[ Wed, Feb 18th 2009 ] - Market Wire

ReGen Biologics Initiates Training Program for U.S. Surgeons

[ Wed, Feb 18th 2009 ] - Market Wire

Alkermes Announces Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD

[ Wed, Feb 18th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. h Quarter and Full Year 2008 Financial Results, a

[ Wed, Feb 18th 2009 ] - Market Wire

Allion Healthcare Announces Date of Fourth Quarter 2008 Financial Results and Conference Call

[ Wed, Feb 18th 2009 ] - Market Wire

Dyax Corp. to Host Fourth Quarter and Year End 2008 Earnings Call and Webcast

[ Wed, Feb 18th 2009 ] - Market Wire

IsoRay, Inc. Announces Distribution Agreement with BrachySciences

[ Wed, Feb 18th 2009 ] - Market Wire

GTx Announces Toremifene 80 mg NDA Accepted for Review by FDA

[ Wed, Feb 18th 2009 ] - Market Wire

Emeritus Announces Resignation of Chief Operating Officer

[ Wed, Feb 18th 2009 ] - Market Wire

Incyte Reports Fourth Quarter and Year-End 2008 F .. ancial Results; Announces 2009 Financial Guidance

[ Wed, Feb 18th 2009 ] - Market Wire

High-Throughput Genotyping of AML Patients for a .. eptor May Significantly Improve Treatment Outcome

Tue, February 17, 2009

[ Tue, Feb 17th 2009 ] - Market Wire

Teva Invites Public to Listen to Investor & Analyst Meeting Webcast

[ Tue, Feb 17th 2009 ] - Paula Catchpole

New Study From Plastic and Reconstructive Surgery Journal Shows How Not To Look Old.

[ Tue, Feb 17th 2009 ] - Market Wire

Remedent, Inc.: Remedent Engages Liolios Group to Lead New Investor Relations Program

[ Tue, Feb 17th 2009 ] - Market Wire

Quova, Inc.: Quova Provides Wi-Fi Triangulation Data to Absolute Software

[ Tue, Feb 17th 2009 ] - Market Wire

Depomed Initiates Phase I Trial for DM-1992 Progr .. lowing Positive Results of Preclinical Studies Sp

[ Tue, Feb 17th 2009 ] - Market Wire

AVANIR Announces Fiscal 2009 First Quarter Financial Results

[ Tue, Feb 17th 2009 ] - Market Wire

Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results

[ Tue, Feb 17th 2009 ] - Market Wire

Affymax Announces $42 Million Private Placement

[ Tue, Feb 17th 2009 ] - Market Wire

BioSante Pharmaceuticals, Inc. Presents LibiGel® .. nical and Market Information at ISSWSH Conference

[ Tue, Feb 17th 2009 ] - Market Wire

St. Jude Medical Welcomes Introduction of Legislation to Help People Suffering From Pain

[ Tue, Feb 17th 2009 ] - Market Wire

Sepracor Announces Tender Offer for 0% Convertible Senior Subordinated Notes Due 2024

[ Tue, Feb 17th 2009 ] - Market Wire

Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections

[ Tue, Feb 17th 2009 ] - Market Wire

Natus Medical to Hold 2008 Fourth Quarter Financial Results Conference Call on February 26

[ Tue, Feb 17th 2009 ] - Market Wire

California Hospital Implements ZOLL AutoPulse

[ Tue, Feb 17th 2009 ] - Market Wire

Inspire Announces Date for Conference Call and We .. urth Quarter and Full Year 2008 Financial Results

[ Tue, Feb 17th 2009 ] - Market Wire

Acorda Therapeutics to Host Conference Call to Re .. Year 2008 Financial Results on February 24, 2009

[ Tue, Feb 17th 2009 ] - Market Wire

GTX Reports Fourth Quarter and Year End 2008 Results

[ Tue, Feb 17th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Baxter I .. nal, Marriott International, UDR, AIV and Vornado

Mon, February 16, 2009

[ Mon, Feb 16th 2009 ] - Market Wire

Constellation Software Inc.: Constellation Softwa .. Call to Discuss Fourth Quarter and Annual Results

[ Mon, Feb 16th 2009 ] - Market Wire

Wright Medical Group, Inc. to Participate in The Canaccord Adams Musculoskeletal Conference

[ Mon, Feb 16th 2009 ] - Market Wire

LifeVantage Corporation Announces the Addition of .. ing Network Marketing Distributors and Executives

[ Mon, Feb 16th 2009 ] - Market Wire

Applied Biosystems and Baylor College of Medicine .. ons to First Data Release of 1000 Genomes Project

Fri, February 13, 2009

[ Fri, Feb 13th 2009 ] - Market Wire

Signature Eyewear Reports Net Income for 2008

[ Fri, Feb 13th 2009 ] - Market Wire

Hypertension Diagnostics: Hypertension Diagnostics Announces FY 2009 Second Quarter Results

[ Fri, Feb 13th 2009 ] - Market Wire

Genta Incorporated Announces Fourth Quarter and Y .. d 2008 Financial Results and Corporate Highlights

[ Fri, Feb 13th 2009 ] - Market Wire

Orthovita to Present at the Roth Capital Partners 21st Annual Growth Stock Conference

[ Fri, Feb 13th 2009 ] - Market Wire

Schaeffer's Street Stories: Cephalon Inc. Struggles with Staunch Technical Resistance

[ Fri, Feb 13th 2009 ] - Market Wire

Amarillo Biosciences, Inc.: Amarillo Biosciences .. o Enroll 165 Patient Phase 2 Hepatitis C Trial in

[ Fri, Feb 13th 2009 ] - Market Wire

Enzon to Release Fourth Quarter 2008 Earnings on .. y 19, 2009; Conference Call and Webcast to Follow

[ Fri, Feb 13th 2009 ] - Market Wire

Universittsklinikum Heidelberg untersucht fortschrittliche Tomotherapie-Bestrahlungstechnik

[ Fri, Feb 13th 2009 ] - Market Wire

MDRNA, Inc.: MDRNA, Inc. Announces Licensing Agreement With Roche

[ Fri, Feb 13th 2009 ] - Market Wire

Bond Laboratories, Inc. Announces the Appointment .. keting Executives as President and Executive Vice

[ Fri, Feb 13th 2009 ] - Market Wire

Mannatech Presents Scientific Posters at Scripps .. icine?s 6th Annual Natural Supplements Conference

[ Fri, Feb 13th 2009 ] - Market Wire

Pioneer Behavioral Health: PHC Reports Second Quarter Fiscal 2009 Results

[ Fri, Feb 13th 2009 ] - Market Wire

Geron Corporation Announces Pricing of Common Stock Offering

[ Fri, Feb 13th 2009 ] - Market Wire

Adrenalina Discloses Its Four Nominees for Election to the Pacific Sunwear Board

[ Fri, Feb 13th 2009 ] - Market Wire

Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. l Partners 21st Annual OC Growth Stock Conference

[ Fri, Feb 13th 2009 ] - Market Wire

Electro-Optical Sciences, Inc.: Electro-Optical S .. op-Line Results From Landmark MelaFind(R) Pivotal

[ Fri, Feb 13th 2009 ] - Market Wire

Obagi Medical Products to Report Fourth Quarter a .. ial Results and Host a Conference Call on March 5

Thu, February 12, 2009

[ Thu, Feb 12th 2009 ] - Market Wire

Osiris Announces Fourth Quarter and Full Year 2008 Financial Results Conference Call

[ Thu, Feb 12th 2009 ] - Market Wire

Theravance, Inc.: Theravance Reports Fourth Quarter and Full Year 2008 Results

[ Thu, Feb 12th 2009 ] - Market Wire

Targacept Reports Fourth Quarter and 2008 Financial Results

[ Thu, Feb 12th 2009 ] - Market Wire

Biovail Announces Fourth-Quarter 2008 Earnings Release, Conference-Call Details

[ Thu, Feb 12th 2009 ] - Market Wire

I-Flow Will Present at the Roth Capital Partners .. nce Wednesday, February 18, 2009 at 4:00 p.m. PST

[ Thu, Feb 12th 2009 ] - Market Wire

InSight Health Services Holdings Corp. to Host Second Quarter Fiscal 2009 Results Conference Call

[ Thu, Feb 12th 2009 ] - Market Wire

American Shared Hospital Services to Develop Prot .. iation Therapy Facility in San Francisco Bay Area

[ Thu, Feb 12th 2009 ] - Market Wire

Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA

[ Thu, Feb 12th 2009 ] - Market Wire

Shareholder Group Led by Adrenalina Announces Nom .. didates for Election to the Pacific Sunwear Board

[ Thu, Feb 12th 2009 ] - Market Wire

Curis Announces Genentech?s Initiation of Pivotal .. rial of GDC-0449 in Advanced Basal Cell Carcinoma

[ Thu, Feb 12th 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Reports Fourth Quarter and Full Year 2008 Results

[ Thu, Feb 12th 2009 ] - Market Wire

BioDelivery Sciences to Present at the ROTH Capit .. l Partners 21st Annual OC Growth Stock Conference

[ Thu, Feb 12th 2009 ] - Market Wire

Antigenics to Report Fourth Quarter and Year-End .. s on February 19, 2009; Conference Call to Follow

[ Thu, Feb 12th 2009 ] - Market Wire

Merck & Co., Inc. Acquires Biologic Manufacturing .. pmental Follow-on Biologics Portfolio from Insmed

[ Thu, Feb 12th 2009 ] - Market Wire

Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction

[ Thu, Feb 12th 2009 ] - Market Wire

Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19

[ Thu, Feb 12th 2009 ] - Market Wire

Emergent BioSolutions anuncia que BioThrax (Vacin .. Antraz) recebe autorizao de comercializao na ndia

Wed, February 11, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan

[ Wed, Feb 11th 2009 ] - Market Wire

Zila Completes First Phase of Global Marketing In .. or Oral Cancer Screening Product, ViziLite® Plus

[ Wed, Feb 11th 2009 ] - Market Wire

Pacific Biometrics, Inc.: Pacific Biometrics to H .. r Conference Call on Wednesday, February 18, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. nce of Claims Relating to Heat Shock Protein dnaJ

[ Wed, Feb 11th 2009 ] - Market Wire

BioElectronics Corporation: BioElectronics Announces Major Shipments

[ Wed, Feb 11th 2009 ] - Market Wire

Lpath, Inc.: Category Leader Lpath Establishes Key 2009 Goals

[ Wed, Feb 11th 2009 ] - Market Wire

Angeion to Announce 2009 First-Quarter Results on Wednesday, February 25

[ Wed, Feb 11th 2009 ] - Market Wire

Orthofix International and The Musculoskeletal Tr .. Accelerate Release Date for Trinity® Evolution"

[ Wed, Feb 11th 2009 ] - Market Wire

Genta Submits Randomized Study of Tesetaxel in Pa .. ric Cancer to FDA for Special Protocol Assessment

[ Wed, Feb 11th 2009 ] - Market Wire

Alnylam and Collaborators Publish New Pre-Clinica .. ivo Efficacy of Systemically Delivered RNAi Thera

[ Wed, Feb 11th 2009 ] - Market Wire

Professor John F. Thompson to Present at the Sixt .. Melanoma and Other Cutaneous Malignancies on Marc

[ Wed, Feb 11th 2009 ] - Market Wire

POZEN Announces February 25, 2009 Webcast of Fourth Quarter and Year End 2008 Results

[ Wed, Feb 11th 2009 ] - Market Wire

Salix Pharmaceuticals to Present at Roth Conference

[ Wed, Feb 11th 2009 ] - Market Wire

Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results

[ Wed, Feb 11th 2009 ] - Market Wire

Gilead pr©sente des donn©es montrant l?activit© d?amplification pharmacocin©tique du GS 9350

[ Wed, Feb 11th 2009 ] - Market Wire

Zacks Industry Outlook Highlights: Pfizer, Eli Lilly, Merck, Sanofi and Schering-Plough

[ Wed, Feb 11th 2009 ] - Market Wire

Micrus Endovascular Initiates VISSIT Trial with Pharos Vitesse Balloon Expandable Stent

Tue, February 10, 2009

[ Tue, Feb 10th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces Publication in The A .. oncerning Blood Volume in Critically Ill Surgical

[ Tue, Feb 10th 2009 ] - Market Wire

Significant Shareholder Calls upon Enzon to Immed .. tely Add Two Candidates to the Board of Directors

[ Tue, Feb 10th 2009 ] - Market Wire

Tenet Announces Definitive Agreement to Sell USC University Hospital

[ Tue, Feb 10th 2009 ] - Market Wire

NeuroMetrix, Inc. Reports Total Revenues of $7.2 Million for the Fourth Quarter of 2008

[ Tue, Feb 10th 2009 ] - Market Wire

Enzon Announces IND Acceptance for Its Survivin Antagonist

[ Tue, Feb 10th 2009 ] - Market Wire

Oculus Innovative Sciences to Present at the Roth .. l Partners 21st Annual OC Growth Stock Conference

[ Tue, Feb 10th 2009 ] - Market Wire

Cougar Biotechnology Announces Agreement with FDA .. nt for Phase III Trial of CB7630 (Abiraterone Ace

[ Tue, Feb 10th 2009 ] - Market Wire

Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics

[ Tue, Feb 10th 2009 ] - Market Wire

Synta Pharmaceuticals Announces First Patient Tre .. Elesclomol Monotherapy Solid Tumor Clinical Study

[ Tue, Feb 10th 2009 ] - Market Wire

Curis Reports Fourth Quarter and Year-End 2008 Financial Results

[ Tue, Feb 10th 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific, Inc. Receives a $200,000 Order for CatPro 5000 System

[ Tue, Feb 10th 2009 ] - Market Wire

Inspire Elects Alan F. Holmer to Board of Directors

[ Tue, Feb 10th 2009 ] - Market Wire

VIVUS Initiates Second Pivotal Phase 3 Trial of Avanafil for Treatment of Erectile Dysfunction

[ Tue, Feb 10th 2009 ] - Market Wire

Natus to Present at the Roth Capital Partners 21st Annual Growth Stock Conference

[ Tue, Feb 10th 2009 ] - Market Wire

Cubist Plans to Commence Patent Infringement Liti .. nteral Medicines, Inc. In Response To ANDA filing

[ Tue, Feb 10th 2009 ] - Market Wire

Dyax and Fovea Sign Development and Commercializa .. ion Agreement for DX-88 in Ophthalmic Indications

[ Tue, Feb 10th 2009 ] - Market Wire

Bioject Extends Supply Agreement with Ferring Pharmaceuticals, Inc.

Mon, February 9, 2009

[ Mon, Feb 09th 2009 ] - Market Wire

Clinical Data Announces Third Quarter Fiscal 2009 Financial Results

[ Mon, Feb 09th 2009 ] - Market Wire

Orthofix International Raises Concerns About Another Ramius Nominee for Orthofix Board

[ Mon, Feb 09th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Initiates .. nnaissance Surveys on Potash Resource in Ethiopia

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences? Security Holders Exer .. any as Result of Recently Announced Strategic Inv

[ Mon, Feb 09th 2009 ] - Market Wire

Curis Announces Collaborative Agreement between G .. nentech and National Cancer Institute on GDC-0449

[ Mon, Feb 09th 2009 ] - Market Wire

Synovis Life Technologies to Present at 21st Annu .. Capital Partners Growth Stock Conference Feb. 18

[ Mon, Feb 09th 2009 ] - Market Wire

Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer?s Disease

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences Announces Fiscal Third .. and Corporate Update Release and Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

UnitedHealth Group Awarded LEED® Green Building Certification

[ Mon, Feb 09th 2009 ] - Market Wire

Synta Pharmaceuticals Names Dr. Vojo Vukovic, Vice President, Clinical Research

[ Mon, Feb 09th 2009 ] - Market Wire

Theragenics Corporation® Announces Schedule for Fourth Quarter and Year-End 2008 Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

Compugen Appoints Dov Hershberg Chairman of the Board

[ Mon, Feb 09th 2009 ] - Market Wire

Inhibitex Completes Phase I Clinical Trials for F .. ad HCV Compounds for Advanced Preclinical Studies

[ Mon, Feb 09th 2009 ] - Market Wire

Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine

[ Mon, Feb 09th 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009

[ Mon, Feb 09th 2009 ] - Market Wire

EPIX Pharmaceuticals Provides Update on NASDAQ Listing Status

[ Mon, Feb 09th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Biogen Idec, CEMEX, Ford, Tata Motors and Carmike Cinemas

Sun, February 8, 2009

[ Sun, Feb 08th 2009 ] - Market Wire

Riassunto: Nei pazienti affetti da sclerosi multi .. malattia non manifesta attivit per due anni, seco

[ Sun, Feb 08th 2009 ] - Market Wire

MS Patients Treated with TYSABRI® Remain Free of .. s, According to Data Published in the Lancet Neur

Fri, February 6, 2009

[ Fri, Feb 06th 2009 ] - Market Wire

Celgene Corporation to Present at the 11th Annual BIO CEO Investor Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Proton Laboratories Inc.: Proton Labs to Begin Bottling Functional Water

[ Fri, Feb 06th 2009 ] - Market Wire

Geron to Present at BIO CEO & Investor Conference

[ Fri, Feb 06th 2009 ] - Market Wire

MEDNAX to Present at UBS Global Healthcare Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10

[ Fri, Feb 06th 2009 ] - Market Wire

Span-America Announces Termination of Hill-Rom Supply Contract

[ Fri, Feb 06th 2009 ] - Market Wire

CIGNA Announces Appearance at the UBS Global Healthcare Services Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Odyssey Healthcare to Broadcast Its Fourth Quarte .. ear-End 2008 Conference Call Live on the Internet

[ Fri, Feb 06th 2009 ] - Market Wire

LifePoint Hospitals to Broadcast Its Fourth Quart .. ear-End 2008 Conference Call Live on the Internet

[ Fri, Feb 06th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma to Present .. l Partners 21st Annual OC Growth Stock Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Advanced Medical Optics, Inc. Gives Notice of Ant .. nd Merger to Holders of Convertible Senior Subord

[ Fri, Feb 06th 2009 ] - Market Wire

Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2009 Financial Results

[ Fri, Feb 06th 2009 ] - Market Wire

Medtronic Completes Acquisition of Ablation Frontiers

[ Fri, Feb 06th 2009 ] - Market Wire

Ligand Enters into Screening Agreement with Trevena

[ Fri, Feb 06th 2009 ] - Market Wire

Biogen Idec Receives Shareholder Proposal

[ Fri, Feb 06th 2009 ] - Market Wire

Health Management Associates, Inc. Announces Four .. ear-End 2008 Earnings Conference Call and Webcast

[ Fri, Feb 06th 2009 ] - Market Wire

The Genome Center at Washington University Scales-Up on Illumina Sequencers

Thu, February 5, 2009

[ Thu, Feb 05th 2009 ] - Market Wire

Health Discovery Corporation Licenses New Prostate Cancer Test to Abbott

[ Thu, Feb 05th 2009 ] - Market Wire

Aetna Awarded $150,000 to Northern California Nonprofits in 2008

[ Thu, Feb 05th 2009 ] - Market Wire

FORTIS: Fortis publishes explanatory document on voting at General Meeting

[ Thu, Feb 05th 2009 ] - Market Wire

Certified Diabetic Services, Inc. Terminates Asset Purchase Agreement

[ Thu, Feb 05th 2009 ] - Market Wire

BioSante Pharmaceuticals, Inc. To Present At BIO CEO and Investor Conference and ISSWSH Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Progen-Avexa Merger Notice of Meeting and Independent Expert Report

[ Thu, Feb 05th 2009 ] - Market Wire

GeneThera: GeneThera Offers Discounted Johne's Di .. ted by Government's Call to Eliminate 400,000 Hea

[ Thu, Feb 05th 2009 ] - Market Wire

Applied Biosystems Awards Genomic Research Grant to St. Jude Children?s Research Hospital

[ Thu, Feb 05th 2009 ] - Market Wire

StemCells, Inc. to Present at the 11th Annual BIO CEO & Investor Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Dr. Reddy?s Announces Five ANDA Approvals and Generic Product Launches in the US Market

[ Thu, Feb 05th 2009 ] - Market Wire

GTx, Inc. Announces Fourth Quarter and Year End 2008 Corporate Results Conference Call and Webcast

[ Thu, Feb 05th 2009 ] - Market Wire

BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B

[ Thu, Feb 05th 2009 ] - Market Wire

Cytori Patent Allowance Expands Celution® System .. n for Adipose Stem & Regenerative Cell Processing

[ Thu, Feb 05th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. he 2009 UBS Global Healthcare Services Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Myriad G .. , School Specialty, Exxon, Chevron and Transocean

[ Thu, Feb 05th 2009 ] - Market Wire

Illumina Presents Development Roadmap for Scaling its Genome Analyzer

[ Thu, Feb 05th 2009 ] - Market Wire

Exelixis Announces February 10 Webcast of Present .. at the 11th Annual BIO CEO & Investor Conference

Wed, February 4, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Sun Healthcare Group, Inc.: Sun Healthcare Group, .. ; Schedules Conference Call to Announce 2008 Earn

[ Wed, Feb 04th 2009 ] - Market Wire

Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference

[ Wed, Feb 04th 2009 ] - Market Wire

COPAXONE® is Approved for Treatment of Patients .. t Clinical Event Suggestive of Multiple Sclerosis

[ Wed, Feb 04th 2009 ] - Market Wire

Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares

[ Wed, Feb 04th 2009 ] - Market Wire

Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of

[ Wed, Feb 04th 2009 ] - Market Wire

Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry

[ Wed, Feb 04th 2009 ] - Market Wire

Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices

[ Wed, Feb 04th 2009 ] - Market Wire

Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,

[ Wed, Feb 04th 2009 ] - Market Wire

Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3

[ Wed, Feb 04th 2009 ] - Market Wire

Progenics Appoints Peter J. Crowley as Independent Board Member

[ Wed, Feb 04th 2009 ] - Market Wire

UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards

[ Wed, Feb 04th 2009 ] - Market Wire

EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening

[ Wed, Feb 04th 2009 ] - Market Wire

Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System

[ Wed, Feb 04th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf

[ Wed, Feb 04th 2009 ] - Market Wire

MEDNAX, Inc. Acquires Neonatal Practice

[ Wed, Feb 04th 2009 ] - Market Wire

Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures

Tue, February 3, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

AVANIR to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

LifePoint Hospitals to Participate in 2009 UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Edwards Lifesciences : Strong Heart Valve Sales Drive Edwards Lifesciences' Fourth Quarter Results

[ Tue, Feb 03rd 2009 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics to Announce Four .. Quarter and Year End Results on February 10, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

CardioNet, Inc. to Release Fourth Quarter and Full Year 2008 Earnings Results on February 17, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Trimeris Reports Fourth Quarter 2008 FUZEON® Sales Results

[ Tue, Feb 03rd 2009 ] - Market Wire

Ligand to Present at BIO CEO and Investor Conference on February 9

[ Tue, Feb 03rd 2009 ] - Market Wire

CombinatoRx to Present at 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Genzyme Center Wins Prestigious Architecture Award

[ Tue, Feb 03rd 2009 ] - Market Wire

MedaSorb Technologies Corporation: MedaSorb Technologies Corporation Improves Balance Sheet

[ Tue, Feb 03rd 2009 ] - Market Wire

NexMed to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Schaeffer's Sentiment Snapshot: Kinetic Concepts, Inc. (KCI)

[ Tue, Feb 03rd 2009 ] - Market Wire

Molecular Insight Pharmaceuticals, Inc. : Molecul .. Inc. to Present at BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Humana Inc. to Present at 2009 UBS Global Health Service Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Remedent, Inc. to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Universal American Corp. Schedules Fourth Quarter .. or Tuesday, February 17th and Conference Call for

[ Tue, Feb 03rd 2009 ] - Market Wire

HemoBioTech Announces Addition of R. E. Corky Dragoo, Jr. to Board of Directors

Oculus Innovative Sciences to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

_{//health-fitness.news-articles.net/content/2009/ .. ners-21st-annual-oc-growth-stock-conference.html}
^{Published in Health and Fitness on Tuesday, February 10th 2009 at 5:55 GMT, Last Modified on 2009-02-10 05:55:41 by Market Wire}

PETALUMA, Calif.--([ BUSINESS WIRE ])--Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) today announced that Hoji Alimi, the company's CEO and founder, will present a corporate overview and business update at the Roth Capital Partners 21st Annual OC Growth Stock Conference to be held at the Ritz Carlton in Laguna Niguel, California. Mr. Alimi's presentation is scheduled on Monday, February 16, 2009 at 2:40 p.m. PST, with a breakout session to immediately follow.

The presentation will be broadcast live and replayed for 90 days on Oculus Innovative Sciences' website at [ http://ir.oculusis.com/events.cfm ]. To listen to the live broadcast, please visit the website at least 15 minutes early to register and download any necessary audio software.

Participation in the conference is by invitation only. For more information on the conference, please contact your Roth representative or visit [ www.rothcp.com ].

About Oculus

Oculus Innovative Sciences develops, manufactures and markets a family of products based upon the Microcyn^® Technology platform, which is intended to help prevent and treat infections in chronic and acute wounds. The Microcyn Technology platform features a biocompatible, shelf-stable solution containing active oxychlorine compounds that is currently commercialized in the United States, Europe, India, China and Mexico for the treatment of infected wounds. The solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores. The company's headquarters are in Petaluma, California, with operations in Europe and Latin America. More information can be found at [ www.oculusis.com ].

Oculus and Microcyn are trademarks or registered trademarks of Oculus Innovative Sciences, Inc. All other trademarks and service marks are the property of their respective owners.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Mon, Feb 09th 2009 ] - Market Wire

LifeVantage Corporation to Present at ROTH Capita .. l OC Growth Stock Conference on February 16, 2009

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences? Security Holders Exer .. any as Result of Recently Announced Strategic Inv

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences Announces Fiscal Third .. and Corporate Update Release and Conference Call

[ Fri, Feb 06th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma to Present .. l Partners 21st Annual OC Growth Stock Conference

[ Wed, Feb 04th 2009 ] - Market Wire

Conceptus® to Present at the ROTH 21st Annual OC Growth Stock Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in

[ Tue, Jan 27th 2009 ] - Market Wire

Oculus Innovative Sciences Announces $3 Million I .. tner to Fund Oculus to Profitability in 12 Months

[ Mon, Jan 26th 2009 ] - Market Wire

Oculus Innovative Sciences Reduces Additional Cas .. ion as Company Targets Breakeven Within 12 Months

[ Tue, Dec 23rd 2008 ] - Market Wire

Oculus Innovative Sciences Announces Stock Listing Remains on NASDAQ

[ Mon, Dec 22nd 2008 ] - Market Wire

St. Jude Medical Acquires MediGuide

[ Tue, Dec 02nd 2008 ] - Market Wire

Oculus Innovative Sciences Announces Agreement wi .. Development of Microcyn Technology Use in Taiwa

[ Wed, Nov 26th 2008 ] - Market Wire

Oculus Innovative Sciences Receives NASDAQ Notification